BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38278585)

  • 1. Newer Immunosuppressants for Rheumatologic Disease: Preoperative Considerations.
    Koh YR; Cummings KC
    Anesthesiol Clin; 2024 Mar; 42(1):131-143. PubMed ID: 38278585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer Immunosuppressants for Rheumatologic Disease: Preoperative Considerations.
    Koh YR; Cummings KC
    Rheum Dis Clin North Am; 2024 Aug; 50(3):545-557. PubMed ID: 38942584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Management of Rheumatic Disease and Therapies.
    Zisa D; Goodman SM
    Rheum Dis Clin North Am; 2022 May; 48(2):455-466. PubMed ID: 35400371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative care for patients with rheumatic diseases.
    Akkara Veetil BM; Bongartz T
    Nat Rev Rheumatol; 2011 Nov; 8(1):32-41. PubMed ID: 22083219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative Management of Rheumatic Disease and Therapies.
    Zisa D; Goodman SM
    Med Clin North Am; 2021 Mar; 105(2):273-284. PubMed ID: 33589102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    J Arthroplasty; 2022 Sep; 37(9):1676-1683. PubMed ID: 35732511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methotrexate therapy in rheumatologic diseases--an update].
    Cauza E; Dunky A
    Wien Med Wochenschr; 2003; 153(13-14):291-4. PubMed ID: 12924103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.
    Baker JF; George MD
    Curr Rheumatol Rep; 2019 Mar; 21(5):17. PubMed ID: 30847768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
    Yoon KH
    Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metabolic surgery on immunosuppressive medication use in patients with rheumatic diseases.
    Ma P; Vahibe A; McKenzie T; Hurtado Andrade MD; Vierkant RA; Higa K; Kendrick M; Ghanem OM
    Surg Obes Relat Dis; 2023 Jan; 19(1):28-34. PubMed ID: 36202738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The perioperative use of biologic agents in patients with rheumatoid arthritis.
    Polachek A; Caspi D; Elkayam O
    Autoimmun Rev; 2012 Dec; 12(2):164-8. PubMed ID: 22522087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative handling of immunosuppressive therapy].
    Wagner J; Luber V; Lock JF; Dietz UA; Lichthardt S; Matthes N; Krajinovic K; Germer CT; Knop S; Wiegering A
    Chirurg; 2018 Feb; 89(2):116-121. PubMed ID: 29264628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer anti-rheumatic drugs.
    Abruzzo JL
    Ann Intern Med; 1978 Jul; 89(1):131-3. PubMed ID: 307359
    [No Abstract]   [Full Text] [Related]  

  • 15. [In which rheumatologic diseases is the immunologic etiology of importance?].
    Lenoch F
    Z Gesamte Inn Med; 1969 May; 24(9):136-9. PubMed ID: 5306827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-allergic and immunosuppressive treatment of rheumatism and rheumatoid arthritis].
    Tsenov I
    Vutr Boles; 1972; 11(3):131-2. PubMed ID: 4154529
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactation and Management of Postpartum Disease.
    Bermas BL
    Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gililland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Rheumatol; 2022 Sep; 74(9):1464-1473. PubMed ID: 35722708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1399-1408. PubMed ID: 35718887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.
    Pilla SJ; Quan AQ; Germain-Lee EL; Hellmann DB; Mathioudakis NN
    Curr Diab Rep; 2016 Oct; 16(10):91. PubMed ID: 27525682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.